Myriad Genetics (MYGN) Current Leases (2019 - 2025)
Historic Current Leases for Myriad Genetics (MYGN) over the last 7 years, with Q3 2025 value amounting to $7.9 million.
- Myriad Genetics' Current Leases fell 4148.15% to $7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year decrease of 4148.15%. This contributed to the annual value of $12.8 million for FY2024, which is 2098.77% down from last year.
- According to the latest figures from Q3 2025, Myriad Genetics' Current Leases is $7.9 million, which was down 4148.15% from $9.0 million recorded in Q2 2025.
- In the past 5 years, Myriad Genetics' Current Leases ranged from a high of $17.8 million in Q3 2023 and a low of $7.9 million during Q3 2025
- For the 5-year period, Myriad Genetics' Current Leases averaged around $13.4 million, with its median value being $13.4 million (2022).
- Its Current Leases has fluctuated over the past 5 years, first soared by 2781.95% in 2023, then plummeted by 4148.15% in 2025.
- Myriad Genetics' Current Leases (Quarter) stood at $13.0 million in 2021, then rose by 8.46% to $14.1 million in 2022, then rose by 14.89% to $16.2 million in 2023, then fell by 20.99% to $12.8 million in 2024, then plummeted by 38.28% to $7.9 million in 2025.
- Its Current Leases stands at $7.9 million for Q3 2025, versus $9.0 million for Q2 2025 and $10.9 million for Q1 2025.